# reload+after+2024-01-23 14:47:06.869558
address1§1177 Avenue of the Americas
address2§5th floor
city§New York
state§NY
zip§10036
country§United States
phone§332-216-1147
website§https://sunshinebiopharma.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; SBFM-PL4, an anti-coronavirus treatment compound; and K1.1 mRNA molecules used as anti-cancer agents. It also offers Essential 9, an amino acids capsules; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. Sunshine Biopharma, Inc. is based in New York, New York.
fullTimeEmployees§46
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Steve N. Slilaty Ph.D.', 'age': 71, 'title': 'Chairman, CEO & President', 'yearBorn': 1952, 'fiscalYear': 2022, 'totalPay': 430000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Camille  Sebaaly', 'age': 64, 'title': 'CFO & Secretary', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 930000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Abderrazzak  Merzouki', 'age': 59, 'title': 'COO & Director', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 545000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Robert G. Ferreira', 'age': 61, 'title': 'President of Sunshine Bio Investments Inc', 'yearBorn': 1962, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§-0.908
priceToSalesTrailing12Months§0.33308414
currency§USD
dateShortInterest§1702598400
forwardEps§0.09
exchange§NCM
quoteType§EQUITY
shortName§Sunshine Biopharma Inc.
longName§Sunshine Biopharma, Inc.
firstTradeDateEpochUtc§1644935400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§7909c686-ce8d-3dd2-8c10-62221258e4a3
gmtOffSetMilliseconds§-18000000
targetHighPrice§3.0
targetLowPrice§3.0
targetMeanPrice§3.0
targetMedianPrice§3.0
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§1
quickRatio§4.104
grossMargins§0.35682
ebitdaMargins§-0.41809
trailingPegRatio§None
